| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 02/06/2013 | EP2552206A1 Trycyclic compounds and pbk inhibitors containing the same |
| 02/06/2013 | CN1950082B Bicyclic and bridged nitrogen heterocycles |
| 02/06/2013 | CN102918046A Inhibitors of jnk |
| 02/06/2013 | CN102918045A Substituted pyrrolotriazines as protein kinase inhibitors |
| 02/06/2013 | CN102918043A Pyrrolopyrimidine compounds as inhibitors of CDK4/6 |
| 02/06/2013 | CN102918042A 8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds |
| 02/06/2013 | CN102918035A 2 -amino- pyrimidine derivatives useful as inhibitors of jnk |
| 02/06/2013 | CN102911178A Tripolyindole derivative and preparation method thereof |
| 02/06/2013 | CN102911177A 7-(4-chlorphenyl)-5,6-dihydro-7aH-benzo[h]1,2,4-triazolo[3,4-b]quinazoline-5,6-diketone and synthetic method thereof |
| 02/06/2013 | CN102911176A Preparation method of pemetrexed disodium |
| 02/06/2013 | CN102911175A Preparation method of 2-amino-4-carbonyl-7-(3,4-dimethoxybenzyl)-5-vinyl-6,7-dihydro-3H-pyrrolo-[2,3-d]pyrimidine |
| 02/06/2013 | CN102911161A 病毒聚合酶抑制剂 Viral polymerase inhibitors |
| 02/06/2013 | CN102911112A Heterocyclic compound and organic light-emitting device including the same |
| 02/06/2013 | CN101861321B Pyrrolo [2, 3 -D] pyrimidin derivatives as protein kinase B inhibitors |
| 02/06/2013 | CN101657455B Compounds for the treatment of hepatitis C |
| 02/06/2013 | CN101528743B Fused heterocyclic derivatives and methods of use |
| 02/06/2013 | CN101466714B Purinone derivatives as HM74A agonists |
| 02/06/2013 | CN101389632B Spiroketals |
| 02/06/2013 | CN101142218B Pyrrolopyrimidines useful as inhibitors of protein kinase |
| 02/05/2013 | US8368062 Nitrogen-containing heterocyclic compound and organic electronic device using the same |
| 02/05/2013 | US8367828 PPAR active compounds |
| 02/05/2013 | US8367826 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 02/05/2013 | US8367694 Carboline derivatives useful in the inhibition of angiogenesis |
| 02/05/2013 | US8367681 Pyrazolopyrimidines and related heterocycles as kinase inhibitors |
| 02/05/2013 | US8367670 Modulators of toll-like receptors |
| 02/05/2013 | US8367653 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 02/05/2013 | CA2709176C Reverse transcriptase inhibitors |
| 02/05/2013 | CA2600478C Imidazopyridazine compounds |
| 02/05/2013 | CA2589127C 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors |
| 01/31/2013 | WO2013016193A2 Activators of class i histone deacetlyases (hdacs) and uses thereof |
| 01/31/2013 | WO2013015535A2 Novel pyrimidine derivative and pharmaceutical composition including same as an active ingredient |
| 01/31/2013 | WO2013014627A1 Pyrazoline derivatives and their use as selective androgen receptor modulators |
| 01/31/2013 | WO2013014567A1 Indazoles |
| 01/31/2013 | WO2013014185A1 Bicyclic pyrimidone compounds |
| 01/31/2013 | WO2013013833A1 Process for the preparation of sitagliptin and its pharmaceutically acceptable salts |
| 01/31/2013 | WO2013013503A1 2,3-dihydroimidazo[1,2-c] pyrimidin-5(1h)-one compounds use as lp-pla2 inhibitors |
| 01/31/2013 | WO2012022681A3 Heterocyclyl pyrazolopyrimidine analogues as selective jak inhibitors |
| 01/31/2013 | US20130030179 Process for the preparation of varenicline |
| 01/31/2013 | US20130030176 Processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine |
| 01/31/2013 | US20130030174 Composition for reducing skin wrinkles including pde5 inhibitor |
| 01/31/2013 | US20130030173 Process for the preparation of small molecule inhibitors of mdm2 and intermediates used therein |
| 01/31/2013 | US20130030170 Enantioselective cyclopropenation of alkynes |
| 01/31/2013 | US20130030012 Compounds |
| 01/31/2013 | US20130029993 Azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors |
| 01/31/2013 | US20130029982 Heterocyclic compounds and uses thereof |
| 01/31/2013 | US20130029981 Compounds, compositions, and methods for controlling biofilms |
| 01/31/2013 | US20130029980 Flavin derivatives |
| 01/31/2013 | US20130029974 6,7-dihydroimidazo[1,5-a]pyrazin-8(5h)-one derivatives as protein kinase modulators |
| 01/31/2013 | US20130029971 Cxcr3 receptor antagonists |
| 01/31/2013 | US20130029968 Indazoles |
| 01/31/2013 | US20130029944 Inhibitors of protein kinases |
| 01/31/2013 | US20130028872 Composition and method for differentiation of human embryonic stem cells |
| 01/31/2013 | CA2843102A1 Bicyclic pyrimidone compounds |
| 01/31/2013 | CA2842965A1 2,3-dihydroimidazo[1,2-c] pyrimidin-5(1h)-one compounds use as lp-pla2 inhibitors |
| 01/31/2013 | CA2842566A1 Pyrazoline derivatives and their use as selective androgen receptor modulators |
| 01/31/2013 | CA2842524A1 Activators of class i histone deacetlyases (hdacs) and uses thereof |
| 01/31/2013 | CA2841882A1 Indazoles |
| 01/30/2013 | EP2551271A1 Copolymer containing fluorenylporphyrin-benzene, preparation method and use thereof |
| 01/30/2013 | EP2551270A2 Pyrazolopyrmidine derivatives for use as pi3 kinase antagonists |
| 01/30/2013 | EP2551259A1 Sitagliptin intermediate compounds, preparation methods and uses thereof |
| 01/30/2013 | EP2550275A1 Pyrrolo[2,l-c][l,4]benzodiazepine-benzothiazole or benzoxazole conjugates linked through piperazine moiety and process for the preparation thereof |
| 01/30/2013 | EP2550274A1 Pyrrolopyrazine derivatives and their use as jak and syk inhibitors |
| 01/30/2013 | EP2550273A2 Pyrrolopyrazine kinase inhibitors |
| 01/30/2013 | EP2550272A1 Pyrazolopyrazine kinase inhibitors |
| 01/30/2013 | EP2550266A2 Heterocyclic compounds useful for kinase inhibition |
| 01/30/2013 | EP2550262A1 Analogues for the treatment or prevention of flavivirus infections |
| 01/30/2013 | EP2549868A1 Chemical compounds |
| 01/30/2013 | CN102906215A Photochromic material |
| 01/30/2013 | CN102906110A Antimicrobial agents based on hemin derivatives |
| 01/30/2013 | CN102906095A Pyrrolopyrazine derivatives as SYK and JAK inhibitors |
| 01/30/2013 | CN102906094A Aminoalcohol substituted 2, 3-dihydroimidazo[1,2-c] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 01/30/2013 | CN102906093A Novel nk-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in nk-3 receptors mediated disorders |
| 01/30/2013 | CN102906092A Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor |
| 01/30/2013 | CN102906083A Novel substituted triazole derivatives as gamma secretase modulators |
| 01/30/2013 | CN102898431A Self-assembly zinc phthalocyanine and synthetic method thereof |
| 01/30/2013 | CN102898430A Preparation method and use of porphyrin micro/nano rods |
| 01/30/2013 | CN102898429A Recrystallization method for controlling crystal shape and narrow particle size distribution of epsilon-HNIW |
| 01/30/2013 | CN102898428A Microwave synthesis method of spirocyclopiperazinium compound |
| 01/30/2013 | CN102898377A Novel phthalazinone derivatives and uses thereof |
| 01/30/2013 | CN102898330A Colchicine derivative |
| 01/30/2013 | CN101914100B Benzenesulfonyl lupetazin derivative and preparation method thereof |
| 01/30/2013 | CN101821268B Tetracyclic compounds for the treatment of hepatitis c |
| 01/30/2013 | CN101687874B Pyrrolotriazine kinase inhibitors |
| 01/29/2013 | US8362276 Reacting a vinyl sulfone compound with imide compound in presence of catalyst |
| 01/29/2013 | US8362275 Dihalogen indolocarbazole monomers and poly(indolocarbazoles) |
| 01/29/2013 | US8362264 Compositions and methods for the treatment of disease associated with Trp-p8 expression |
| 01/29/2013 | US8362245 Processes for preparing intermediates of pemetrexed |
| 01/29/2013 | US8362058 Bicyclic compound, production and use thereof |
| 01/29/2013 | US8362023 Pyrazolo pyrimidines |
| 01/29/2013 | US8362007 Substituted noribogaine |
| 01/29/2013 | US8362006 Processes for making zilpaterol and salts thereof |
| 01/29/2013 | US8361962 Tricyclic inhibitors of JAK |
| 01/29/2013 | CA2672860C Inhibitors of poly(adp-ribose)polymerase |
| 01/29/2013 | CA2544492C Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties |
| 01/29/2013 | CA2460000C Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 01/24/2013 | WO2013013031A1 Pyridazino [4, 5 -d] pyrimidin- (6h) -one inhibitors of wee - 1 kinase |
| 01/24/2013 | WO2013012915A1 Heterocyclic compounds and uses thereof |
| 01/24/2013 | WO2013012297A1 Novel organic electroluminescence compounds and organic electroluminescence device using the same |
| 01/24/2013 | WO2013012296A1 Novel organic electroluminescence compounds and organic electroluminescence device using the same |
| 01/24/2013 | WO2013011891A1 Nitrogenated aromatic heterocyclic derivative, and organic electroluminescent element using same |